CMS Coverage Of Post-Approval Studies Seeks To Improve Data For NCDs
This article was originally published in The Gray Sheet
Executive Summary
CMS' decision to pay for carotid artery stenting with embolic protection in post-approval studies advances the agency's interest in efficiently gathering data to better inform national coverage determinations